Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Inactivated SARS-CoV-2 vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
December 29, 2021
Lead Product(s) : Inactivated SARS-CoV-2 vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Acyclovir
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Pharma Metric Labs
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 03, 2021
Lead Product(s) : Acyclovir
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Pharma Metric Labs
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Furosemide
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Pharma Metric Labs
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 29, 2021
Lead Product(s) : Furosemide
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Pharma Metric Labs
Deal Size : Inapplicable
Deal Type : Inapplicable